Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

The Nuclear Receptor Field: A Historical Overview and Future Challenges.

Mazaira GI, Zgajnar NR, Lotufo CM, Daneri-Becerra C, Sivils JC, Soto OB, Cox MB, Galigniana MD.

Nucl Receptor Res. 2018;5. pii: 101320. doi: 10.11131/2018/101320. Epub 2018 Jul 26.

2.

A before-after study of hospital use in two frail populations receiving different home-based services over the same time in Vancouver, Canada.

McGregor MJ, Cox MB, Slater JM, Poss J, McGrail KM, Ronald LA, Sloan J, Schulzer M.

BMC Health Serv Res. 2018 Apr 5;18(1):248. doi: 10.1186/s12913-018-3040-y.

3.

BUILDing SCHOLARS: enhancing diversity among U.S. biomedical researchers in the Southwest.

Collins TW, Aley SB, Boland T, Corral G, Cox MB, Echegoyen LE, Grineski SE, Morera OF, Nazeran H.

BMC Proc. 2017 Dec 4;11(Suppl 12):12. doi: 10.1186/s12919-017-0095-4. eCollection 2017.

4.

Evidence for Hsp90 Co-chaperones in Regulating Hsp90 Function and Promoting Client Protein Folding.

Cox MB, Johnson JL.

Methods Mol Biol. 2018;1709:397-422. doi: 10.1007/978-1-4939-7477-1_28. Review.

PMID:
29177674
5.

Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.

Joshi JB, Patel D, Morton DJ, Sharma P, Zou J, Hewa Bostanthirige D, Gorantla Y, Nagappan P, Komaragiri SK, Sivils JC, Xie H, Palaniappan R, Wang G, Cox MB, Chaudhary J.

Mol Oncol. 2017 Apr;11(4):337-357. doi: 10.1002/1878-0261.12028. Epub 2017 Mar 2.

6.

The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling.

Maiarù M, Tochiki KK, Cox MB, Annan LV, Bell CG, Feng X, Hausch F, Géranton SM.

Sci Transl Med. 2016 Feb 10;8(325):325ra19. doi: 10.1126/scitranslmed.aab3376.

7.

Similarities and Distinctions in Actions of Surface-Directed and Classic Androgen Receptor Antagonists.

Suh JH, Chattopadhyay A, Sieglaff DH, Storer Samaniego C, Cox MB, Webb P.

PLoS One. 2015 Sep 2;10(9):e0137103. doi: 10.1371/journal.pone.0137103. eCollection 2015.

8.

The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling.

Storer Samaniego C, Suh JH, Chattopadhyay A, Olivares K, Guy N, Sivils JC, Dey P, Yumoto F, Fletterick RJ, Strom AM, Gustafsson JÅ, Webb P, Cox MB.

PLoS One. 2015 Jul 24;10(7):e0134015. doi: 10.1371/journal.pone.0134015. eCollection 2015.

9.

Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease.

Guy NC, Garcia YA, Cox MB.

Curr Mol Pharmacol. 2015;9(2):109-25. Review.

PMID:
25986565
10.

Tetratricopeptide repeat domain 9A negatively regulates estrogen receptor alpha activity.

Shrestha S, Sun Y, Lufkin T, Kraus P, Or Y, Garcia YA, Guy N, Ramos P, Cox MB, Tay F, Lin VC.

Int J Biol Sci. 2015 Feb 27;11(4):434-47. doi: 10.7150/ijbs.9311. eCollection 2015.

11.
12.

Functions of the Hsp90-binding FKBP immunophilins.

Guy NC, Garcia YA, Sivils JC, Galigniana MD, Cox MB.

Subcell Biochem. 2015;78:35-68. doi: 10.1007/978-3-319-11731-7_2. Review.

PMID:
25487015
13.

The Hsp90 ensemble: coordinated Hsp90-cochaperone complexes regulate diverse cellular processes.

Schwenkert S, Hugel T, Cox MB.

Nat Struct Mol Biol. 2014 Dec;21(12):1017-21. doi: 10.1038/nsmb.2927. No abstract available.

PMID:
25469839
14.

A role for synapsin in FKBP51 modulation of stress responsiveness: Convergent evidence from animal and human studies.

Schmidt U, Buell DR, Ionescu IA, Gassen NC, Holsboer F, Cox MB, Novak B, Huber C, Hartmann J, Schmidt MV, Touma C, Rein T, Herrmann L.

Psychoneuroendocrinology. 2015 Feb;52:43-58. doi: 10.1016/j.psyneuen.2014.11.005. Epub 2014 Nov 11.

PMID:
25459892
15.

Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer.

Liang S, Bian X, Liang D, Sivils JC, Neckers LM, Cox MB, Xie H.

Pharm Dev Technol. 2016;21(1):121-6. doi: 10.3109/10837450.2014.979946. Epub 2014 Nov 7.

16.

Bioavailability and fate of sediment-associated trenbolone and estradiol in aquatic systems.

Sangster JL, Zhang Y, Hernandez R, Garcia YA, Sivils JC, Cox MB, Snow DD, Kolok AS, Bartelt-Hunt SL.

Sci Total Environ. 2014 Oct 15;496:576-584. doi: 10.1016/j.scitotenv.2014.07.040. Epub 2014 Aug 8.

PMID:
25108798
17.

NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity.

Erlejman AG, De Leo SA, Mazaira GI, Molinari AM, Camisay MF, Fontana V, Cox MB, Piwien-Pilipuk G, Galigniana MD.

J Biol Chem. 2014 Sep 19;289(38):26263-76. doi: 10.1074/jbc.M114.582882. Epub 2014 Aug 7.

18.

Affinity purification probes of potential use to investigate the endogenous Hsp70 interactome in cancer.

Rodina A, Taldone T, Kang Y, Patel PD, Koren J 3rd, Yan P, DaGama Gomes EM, Yang C, Patel MR, Shrestha L, Ochiana SO, Santarossa C, Maharaj R, Gozman A, Cox MB, Erdjument-Bromage H, Hendrickson RC, Cerchietti L, Melnick A, Guzman ML, Chiosis G.

ACS Chem Biol. 2014 Aug 15;9(8):1698-705. doi: 10.1021/cb500256u. Epub 2014 Jun 17.

19.

The cochaperone SGTA (small glutamine-rich tetratricopeptide repeat-containing protein alpha) demonstrates regulatory specificity for the androgen, glucocorticoid, and progesterone receptors.

Paul A, Garcia YA, Zierer B, Patwardhan C, Gutierrez O, Hildenbrand Z, Harris DC, Balsiger HA, Sivils JC, Johnson JL, Buchner J, Chadli A, Cox MB.

J Biol Chem. 2014 May 30;289(22):15297-308. doi: 10.1074/jbc.M113.535229. Epub 2014 Apr 21.

20.

Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52.

Erlejman AG, Lagadari M, Harris DC, Cox MB, Galigniana MD.

Curr Protein Pept Sci. 2014 May;15(3):205-15. Review.

PMID:
24694367

Supplemental Content

Loading ...
Support Center